LOS ANGELES, CA: Pre-Clinical Study to Determine Effectiveness of the Company's Immunotronics™ Platform in Preventing and Reversing Inflammation in Non-Alcoholic Steatohepatitis (NASH)
...
OMER, ISRAEL: Two Studies Presented at DDW 2017 Showed Clinically Meaningful Reduction in Symptoms and Withdrawal or Reduction in Proton Pump Inhibitor Use by Two-Thirds of Patients Following Treatment with MUSE(TM ...
Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.